annb0t
Top 20
MELBOURNE, Australia, Oct. 25, 2022 /PRNewswire/ -- An antiviral barrier nasal spray called VIRALEZE⢠will launch in Hong Kong and Macau in the coming weeks, following a recent sales and distribution agreement between the product's developer Starpharma and Hengan Pharmacare Company Limited, a subsidiary of Hengan International Group Company Limited.
Developed by Australian biotechnology company Starpharma, VIRALEZE⢠is a broad-spectrum nasal spray intended to provide a moisturising an...
>>> Read more: VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau
Developed by Australian biotechnology company Starpharma, VIRALEZE⢠is a broad-spectrum nasal spray intended to provide a moisturising an...
>>> Read more: VIRALEZE Nasal Spray to be distributed in Hong Kong and Macau
